ABSTRACT-The interaction of SM-6586 (methyl 1,4-dihydro-2,6-dimethyl-3-{3-(N-benzyl-N-methyl aminomethyl)-1,2,4-oxadiazolyl-5-yl}-4-(3-nitrophenyl)pyridine-5-carboxylate) with the specific binding of 3H-PN200-110 to rat heart and brain membranes was characterized and compared with those of other Ca 2+ antagonists. The blockade of 3H-PN200-110 binding sites induced by nifedipine, nitrendipine and nimodipine was reversed by washing, whereas the blockade by SM-6586 was not readily reversed under these conditions. No significant difference was found in irreversibility between SM-6586 enantiomers. When rat aortic strips were pretreated with SM-6586, the contractions induced by 50 mM KCl were inhibited even though SM-6586 was not present in the extracellular medium. This residual inhibitory effect was much stronger than that of nicardipine. The inhibition of KCl-induced contractions by nifedipine and nitren dipine was easily reversed by washing. Thus, we suggest that (+)SM-6586 is a novel 1,4-dihydropyridine derivative having a very slow rate of dissociation from the binding site. This property may explain its long lasting antihypertensive effect.
We have previously shown that a novel 1,4-dihydro pyridine derivative, SM-6586 (methyl 1,4-dihydro-2,6 dimethyl-3 -{3-(N-benzyl-N-methylaminomethyl)-1, 2, 4 oxadiazolyl 5 -yl } -4 (3 -nitrophenyl) pyridine 5 carboxyl ate), is as potent as nicardipine, nifedipine, nimodipine and nitrendipine at displacing the specific bindings of 3H nitrendipine and 3H-PN200-110 to rat brain and heart membranes (1) . In experiments with conscious spontane ously hypertensive rats (SHR), SM-6586 has been found to have a long-lasting antihypertensive effect (2, 3) . Ligand binding studies have demonstrated that the long acting dihydropyridine Ca 2+ antagonists strongly bind to the dihydropyridine binding sites in Ca 21 channels and dissociate slowly from these sites (4) (5) (6) . Thus, the long lasting effect of SM-6586 may be attributable to its slow dissociation. To clarify this possibility, we examined the inhibitory effect of SM-6586 observed after its removal on 3H -PN200-110 binding to rat brain and heart membranes and on KCl-induced contractions in rat aorta in compari son with those of other Ca 21 antagonists.
MATERIALS AND METHODS

Radioligands
3H -PN200-110 (87 Ci/mmol) was purchased from New England Nuclear/Du pont, Inc., Boston, MA, USA.
Membrane preparation Membrane-enriched fractions were prepared by the method described previously (1) . In brief, hearts and brains were removed from Wistar rats weighing about 200 300 g and then minced in 10 mM Tris-HC1 contain ing 250 mM sucrose (pH 7.4). The brain was gently homogenized by a glass homogenizer, and the heart was homogenized by a Polytron, twice for 10 sec at setting 8. Both homogenates were filtered through 4 layers of gauze, and the filtrates were centrifuged at 40,000 x g for 30 min. The resultant pellets were immediately rinsed with incubation medium containing 120 mM Tris-HCI buffer and 40 mM MgC12i pH 7.2, and then homogenized in the same medium with a glass (brain) or Polytron (heart) homogenizer. Protein was determined by the method of Lowry et al. (7) .
Binding assay
The membranes were incubated with various concentra tions of 3H-PN200-110 in a total volume of 0.5 ml of 120 mM Tris-HCl buffer and 20 mM MgC12 (pH 7.2) at 23C. After the incubation, the membranes were rapidly vacu um-filtered through a GF/C glass fiber filter. The tissue bound radioactivity was counted with a scintillation counter. The specific binding was defined as the difference in binding determined in the absence and presence of 0.1 mM nifedipine. The specific binding of 3H-PN200-110 to rat heart and brain membrane increased linearly with increasing protein concentrations in the range of 0.05 0.25 mg per assay and was at equilibrium at 40 min (data not shown). Thus, the binding reaction was carried out for 45 min, with a protein concentration of 0.2 mg (heart) and 0.1 mg (brain) per assay. The dissociation con stant (Kd) and maximal binding sites (Bma,{) for heart and brain 3H-PN200-110 binding were estimated by Scatchard analysis of the saturation data over the concentration range of 0.01 -2.5 nM and 0.01 -0.8 nM 3H-PN200-110, respectively.
The inhibitory effects of Ca 2+ antagonists after their removal on 3H-PN200-110 binding were studied accord ing to the method described by Yamada et al. (8, 9) . The membranes were preincubated with Ca2+ antagonists or without added antagonists for 45 min. The preincubated membranes were washed 3 times in 60 mM Tris-HCl buffer and 20 mM MgC12 (pH 7.2) by centrifugation and resuspension. The washed membranes were then assayed for 3H-PN200-110 binding. The concentration of 3H PN200-110 used was 0.06 nM.
Pharmacological experiments
Spirally cut strips of thoracic aortae were obtained from male Wistar rats, weighing 300-350 g, as described previously (1) . After the contractile response to 50 mM KCl was determined, the preparation was incubated with a Ca 2+ antagonist for 30 min and again was exposed to 50 mM KCI. Then, the preparation was washed three times with drug-free Krebs-Henseleit solution. Exposure of the preparation to 50 mM KCl was repeated at inter vals of 30 min until 240 min after removal of the drug. 
RESULTS
The representative saturation isotherms for 3H-PN200 110 and their Scatchard plots are shown in Fig. 1 . The radioligand interacted with a single population of satu rable high-affinity sites in both heart and brain mem branes. The Kd value for 3H-PN200-110 in heart mem branes was significantly higher than that in brain mem branes ( Table 1) .
The reversibility of the inhibition of heart and brain 3H-PN200-110 binding by SM-6586 and other Ca 2+ an tagonists is shown in Fig. 2 Nifedipine (3 x 10-9 M), nitrendipine (3 x 10-9 M), nicardipine (3 x 10-9 M) and SM-6586 (6 x 10-9 M) in hibited 50 mM KCl-induced contractions similarly by 50% in rat aortic strips. The time courses of tension recov ery following the washout of these Ca2+ antagonists are shown in Fig. 3 . The KCl-induced contraction almost completely recovered 60 min after the washout of nifedi pine and 150 min after the washout of nitrendipine.
The time course of recovery was slower when nicardipine was used for pretreatment. When the aortic strips were pretreated with SM-6586, the aortic tension did not sig nificantly recover after repeated washout for 240 min.
There was a good correlation between the inhibition of 3H -PN200-110 binding to the heart and brain membranes and the inhibition of the KCl-induced contraction in rat aortic strips caused by the Ca" antagonists after their removal (Fig. 4) . 
DISCUSSION
We have previously reported that the potency of SM 6586 is comparable to those of nicardipine, nitrendipine, nimodipine and nifedipine in inhibiting 3H-nitrendipine binding and 3H-PN200-110 binding to rat heart and brain membranes (1) . In this study, however, we found that the blockade of 3H-PN200-110 binding sites in the heart and brain induced by nifedipine, nitrendipine and nimodipine was easily reversed by washing, whereas the blockade by SM-6586 or nicardipine was not reversed under these con ditions. This indicates that, in contrast to nifedipine, nitrendipine and nimodipine, once SM-6586 and nicardi pine are bound to their site of action, they are not readily removed by washing. Thus, SM-6586 and nicardipine tightly bind to dihydropyridine binding sites in Ca 21 chan nels and only slowly dissociate from the sites. These properties of SM-6586 and nicardipine may be respon sible for the long-lasting antihypertensive effects seen in SHR models. It seems that the rate of dissociation of SM 6586 may be slower than the rate of dissociation. The residual inhibitory effect of SM-6586 on KCl-induced con tractions in rat aorta was much stronger than those of other Ca 2+ antagonists, including nicardipine. When the aortic strips were pretreated with SM-6586, KCl-induced contractions did not significantly recover even after repeated washout for 240 min.
The importance of the chemical structures for Ca2+ antagonistic actions has been reported (10-12). As sug gested in our previous report (1), SM-6586 is a 1,4-dihy dropyridine derivative, and its important chemical struc tures are 1) the stereochemistry at C-4, 2) the position of the NO2 substitution of the nitrophenyl group, and 3) the N,N-benzyl methylamino substitution of the C-3 in the 1,4-dihydropyridine ring. We did not recognize a differ ence in irreversibility between stereoisomers of SM-6586, indicating that the stereochemistry at C-4 does not play an important role in the irreversible effect of SM-6586. The differences in the structures of nitrendipine and nifedipine are the substitution at C-5 and the position of the NO2 in the nitrophenyl group. These differences might contribute to the different dissociation rates of these an tagonists from the binding sites. Nevertheless, as the dis sociation rate of these antagonists appeared similarly faster than those of SM-6586 and nicardipine, the impor tance of these structural differences for irreversibility may be less meaningful. On the other hand, a substitution at C-3 may be crucial for the irreversibility of the Ca 2+ an tagonists. The order of the molecular size of the substi tution at C-3 was SM-6586 > nicardipine > nimodipine > nitrendipine > nifedipine. Thus, the C-3 substitution of SM-6586 may affect the tight binding of this drug to Ca 21 channels.
In conclusion, although the Ca 2+ antagonistic potency of SM-6586 was almost the same as those of other Ca" antagonists, its binding was the tightest among the drugs tested. These comparative studies suggest that the substi tution at C-3 of the 1,4-dihydropyridine ring, rather than the substitution at C-5 and the position of NO2 substitu tion in the nitrophenol ring, may contribute to the irrever sible Ca 2+ antagonistic effect of SM-6586, leading to the long-lasting antihypertensive effect.
